News

The latest press releases, publications, and events for Innoviva Specialty Therapeutics

Filter by:

All News Press Releases Events

08.31.2020

Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury

Read More

08.29.2020

Angiotensin II for Critically Ill Patients With Shock After Heart Transplant

Read More

08.07.2020

Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study

Read More

07.01.2020

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock

Read More

07.01.2020

Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis

Read More

04.07.2020

COVID-19 and the RAAS—a potential role for angiotensin II?

Read More

03.02.2020

Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis

Read More

02.06.2020

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

Read More

06.03.2019

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

Read More

06.01.2018

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II

Read More